- Home
- DDI vs KMDA Comparison
DDI vs KMDA Comparison
Compare DDI & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- KMDA
- Stock Information
- Founded
- DDI 2008
- KMDA 1990
- Country
- DDI South Korea
- KMDA Israel
- Employees
- DDI N/A
- KMDA N/A
- Industry
- DDI EDP Services
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- KMDA Health Care
- Exchange
- DDI Nasdaq
- KMDA Nasdaq
- Market Cap
- DDI 472.2M
- KMDA 410.6M
- IPO Year
- DDI 2021
- KMDA N/A
- Fundamental
- Price
- DDI $9.35
- KMDA $7.14
- Analyst Decision
- DDI Strong Buy
- KMDA Strong Buy
- Analyst Count
- DDI 5
- KMDA 2
- Target Price
- DDI $19.60
- KMDA $13.00
- AVG Volume (30 Days)
- DDI 48.9K
- KMDA 49.3K
- Earning Date
- DDI 11-10-2025
- KMDA 08-13-2025
- Dividend Yield
- DDI N/A
- KMDA 2.85%
- EPS Growth
- DDI N/A
- KMDA 27.97
- EPS
- DDI 2.15
- KMDA 0.32
- Revenue
- DDI $333,256,000.00
- KMDA $169,517,000.00
- Revenue This Year
- DDI $14.45
- KMDA $14.49
- Revenue Next Year
- DDI $5.69
- KMDA $10.12
- P/E Ratio
- DDI $4.38
- KMDA $21.58
- Revenue Growth
- DDI 0.24
- KMDA 9.67
- 52 Week Low
- DDI $8.09
- KMDA $5.17
- 52 Week High
- DDI $18.21
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- DDI 43.55
- KMDA 49.19
- Support Level
- DDI $9.28
- KMDA $7.01
- Resistance Level
- DDI $9.74
- KMDA $7.27
- Average True Range (ATR)
- DDI 0.24
- KMDA 0.17
- MACD
- DDI -0.01
- KMDA 0.02
- Stochastic Oscillator
- DDI 12.22
- KMDA 45.28
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.